TERAFLEX CHONDROKREM FORTE CREAM 1% + 5% 30G
TERAFLEX CHONDROKREM FORTE CREAM 1% + 5% 30G
Security policy (edit with Customer reassurance module)
Delivery policy (edit with Customer reassurance module)
Return policy (edit with Customer reassurance module)
Teraflex® Hondrokrem Forte.
International non-proprietary or grouping name:
Meloxicam + Chondroitin Sulfate.
Cream for external use.
Chondroitin sodium sulfate - 50 mg, meloxicam - 10 mg.
dimethyl sulfoxide - 100 mg, propylene glycol - 100 mg, macrogol cetostearate - 12 mg, cetostearyl alcohol [cetyl alcohol not more than 60%, stearyl alcohol not less than 40%] - 42 mg, liquid paraffin - 100 mg, petrolatum - 80 mg, imido urea - 3 mg, sodium disulfite - 0.5 mg, water - up to 1.00 g.
Cream from light yellow with a greenish tinge to yellow with a greenish tint color with the smell of dimethyl sulfoxide.
Tissue regeneration stimulator + non-steroidal anti-inflammatory drug.
The drug Terafleks® Hondrokrem Forte has a combined effect: it slows the progression of osteoarthritis and osteochondrosis, has an anesthetic effect, increases the volume of movement of the joints (in the area of application of the cream), has anti-inflammatory effect, reduces swelling of the joints.Due to the optimal combination of the components of the cream, mutual enhancement of their analgesic and anti-inflammatory effects is noted.
Chondroitin sulfate is a high molecular weight mucopolysaccharide, which is a natural component of cartilage tissue. Chondroitin sulfate improves phosphorus-calcium metabolism in cartilage, inhibits enzymes that cause cartilage damage, inhibits the processes of cartilage degeneration (destruction), stimulates the synthesis of glycosaminoglycans, promotes regeneration (restoration) of joint cartilage surfaces, accelerates the processes of their repair, prevents the collapse of the joint,. This leads to a decrease in pain and an increase in mobility of the affected joints.
Meloxicam is a non-steroidal anti-inflammatory agent, it has anti-inflammatory, analgesic action. Meloxicam selectively inhibits cyclooxygenase 2, violates the metabolism of arachidonic acid, reduces the amount of prostaglandins (mediators of pain and inflammation) in the focus of inflammation. Meloxicam is a chondron-neutral drug that does not adversely affect the cartilage tissue, does not affect the synthesis of proteoglycan by articular cartilage chondrocytes.
Indications for use
The drug is recommended for use in the complex treatment of degenerative-dystrophic diseases of the musculoskeletal system: osteoarthritis, spinal osteochondrosis; other diseases of the joints, accompanied by pain.
Hypersensitivity to the components of the drug (as well as to other nonsteroidal anti-inflammatory drugs), violation of the integrity of the skin in the places of the intended application, children's age (up to 12 years).
In violation of the kidneys and liver, with severe pathology of the gastrointestinal tract (peptic ulcer in the acute phase), with severe pathology of the blood system, old age.
Use during pregnancy and lactation
The use of the drug is contraindicated during pregnancy and lactation.
Dosage and administration
Outwardly. Lightly rubbed a strip of cream with a length of 1 to 5 cm, the multiplicity of application - 2-3 times a day. The required amount of the drug depends on the size of the painful area. Wash hands thoroughly after applying the product. The duration of treatment depends on the indications and the effect noted. After 2 weeks of using the drug should consult a doctor.
Allergic reactions from the skin (itching, redness, skin rash) are possible. If any side effects occur, you should stop using the cream and consult a doctor.
Extremely low systemic absorption of the active components of the drug for external use makes overdosing almost impossible.
Interaction with other drugs
Cases of interaction or incompatibility with other drugs are not described.
The drug should be applied only to intact skin, avoiding contact with open wounds. Do not allow contact with the eyes and mucous membranes. You should consult with your doctor before using Teraflex® Hondrokrem Forte with other nonsteroidal anti-inflammatory drugs, as well as when you need to use the drug for more than 2 weeks.
Influence on ability to drive motor transport and control mechanisms
The drug does not cause sedation, psychomotor disorders and does not affect the patient's ability to engage in potentially hazardous activities that require increased attention and speed of mental and motor responses.
At a temperature not higher than 25 ° С.
Keep out of the reach of children.